[ad_1]
Britain will be the first country to receive the new coronavirus vaccine, which is being developed by the University of Oxford, and the results of which are believed to emerge in July.
Pascal Suryot, CEO of AstraZeneca, announced that Britain will have a “priority” to supply the possible vaccine for the “Covid-19” epidemic, and emphasized that the vaccine will be distributed at cost at the time of the epidemic.
The head of the pharmaceutical industry said that by June or July, scientists will know whether the emerging Corona virus vaccine, which is being developed at the University of Oxford, will work.
“The group at Oxford is already one of the best teams in the world. They have moved very fast … and by June or July we will have an idea,” Suryot said in a statement to the British “Sky News” network. First about the effectiveness and safety of this vaccine, and we will have to wait a few more months. “
He added that “production is already continuing,” adding that the pharmaceutical company needs to manufacture enough doses to conduct clinical trials.
“We will expand until we are ready for the fourth quarter (October) so that we can provide a sufficient number, with priority given to the British,” Suryot said.
The company “Astra Zenica” partnered with the University of Oxford to develop, manufacture and distribute the expected vaccine on a large scale, while the university said the two partners agreed to work nonprofit throughout the period of the epidemic, while They covered the costs of production and distribution only, to become a commercial vaccine if the virus does not go away or becomes a flu-like virus.
Sawirot admitted that his company was at risk of making the possible vaccine while clinical trials are still ongoing, but explained: “It is a terrible crisis, as we all know, and we have now decided that it is time to work together and do our best. to help find a solution. “
Human experiments with the vaccine, carried out by the Jenner Institute at the University, began last week, with hundreds of volunteers to be part of the study, which received £ 20m of government funding.
The agreement between Oxford University and AstraZeneca is the first such association to be formed since the British government launched the vaccine working group two weeks ago to help find a vaccine for the new coronavirus, and the health secretary British Matt Hancock described the deal as “very good news”. “
Hankook added: “Science is uncertain, and no vaccine can be successful, but this agreement gives Britain the best possible opportunity to make a breakthrough that can defeat this terrible virus.”
");
//}, 3000);
}
});
//$(window).bind('scroll ');
$ (window) .scroll (function () {
if (alreadyLoaded_facebookConnect == false) {
alreadyLoaded_facebookConnect = true;
// $ (window) .unbind ('scroll');
// console.log ("loaded offset");
(function (d, s, id) {
var js, fjs = d.getElementsByTagName (s)[0];
if (d.getElementById (id)) return;
js = d.createElement (s); js.id = id;
js.async = true;
js._https = true;
js.src = "https://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322";
fjs.parentNode.insertBefore (js, fjs);
} (document, 'script', 'facebook-jssdk'));
// pre_loader ();
// $ (window) .unbind ('mousemove');
// setTimeout (function () {
// $ ('# boxTwitter'). html ("Tweets from @tayyar_org");
//}, 3000);
var scriptTag = document.createElement ("script");
scriptTag.type = "text / javascript"
scriptTag.src = "https://news.google.com/scripts/social.js";
scriptTag.async = true;
document.getElementsByTagName ("head")[0].appendChild (scriptTag);
(function () {
$ .getScript ("https://news.google.com/scripts/social.js", function () {});
});
}
});
//$(window).load(function () {
// setTimeout (function () {
// // add the returned content to a newly created script tag
// var se = document.createElement ('script');
// se.type = "text / javascript";
// //se.async = true;
// se.text = "setTimeout (function () {pre_loader ();}, 5000);";
// document.getElementsByTagName ('body')[0].appendChild (se);
//}, 5000);
//});
[ad_2]
